TISSUE REGENERATION TECHNOLOGIES, LLC
  • Providers
  • About
    • About Softwave
    • Management
    • Board of Managers
    • Board of Advisors
    • Upcoming Events
  • Research
    • FDA
    • Search
    • SoftWave™ Literature
    • Back, Spine, Nerves
    • Biologic Response
    • Bone Healing
    • Brain, Stroke
    • Cardiology
    • Cancer
    • Cosmetics/Aesthetics
    • Dental
    • Integrative Medicine
    • Modulation of Inflammation
    • Opioid Addiction
    • Organ Regeneration
    • Physics
    • Sports Medicine and Orthopedics >
      • OrthoGold User Guide and Protocols
    • Respiratory/Coronavirus
    • Stem Cells
    • Urology >
      • UroGold IRB User Guide and Protocols
    • Sexual Health
    • Veterinary
    • Wound Care >
      • Wound Care Protocols
    • Research Experts
    • Research Centers
    • Shockwave Summary
  • News
  • Products
    • Cardiology
    • DermaGold100
    • Lithotripsy >
      • Lithotripsy Technical Specifications
      • Lithotripsy F2 Zone Comparison
      • Lithotripsy Imaging
    • Orthopedics >
      • OrthoGold 100™
      • OrthoGold 280™
      • Sport orthopedics and traumatology
    • Urology & Sexual Health
    • Veterinary
    • Wound Care
  • TESTIMONIALS
    • Dr Endorsement Testimonals
    • Cardiology - Stroke
    • Cosmetics
    • Neuropathy
    • Orthopedics
    • Urology & Sexual Health
    • Veterinary
    • Wounds
  • Contact
  • Shop
  • Customer Portal
  • New Page
Research > Veterinary
Effect of unfocused extracorporeal shock wave therapy on growth factor gene expression in wounds and intact skin of horses. - PubMed - NCBI - 8 horses were treated with ESWT at 6 locations along the neck at 36, 24, 12, 6, 2, or 1 hour prior to collection of full-thickness biopsy specimens from each location; a control specimen was collected from a sham-treated location. In 6 horses, 5 full-thickness wounds were created in each forelimb. Wounds in 1 forelimb/horse received ESWT immediately after creation and subsequently on days 7, 14, and 21; wounds in the contralateral forelimb remained untreated. Biopsy specimens were collected from 1 wound on each forelimb on days 7, 14, 21, 28, and 35.  More.
​Shock waves for arthritis A new form of therapy offers pain relief using sound waves in pets - Treatment can be used alone or in combination with other therapies. Both young, athletic dogs and geriatric dogs can benefit. One manufacturer is promoting ESWT for four weeks prior to casting on toy dogs with broken legs when it is not possible to use screws. Most studies show significant improvement in a majority of animals treated.  More..
Extracorporeal shock wave therapy: clinical applications and regulation - Shock wave therapy is a relatively new modality for use in equine practice. The application of shock waves is dependent on an accurate diagnosis and localization of the lesion. At this time we are still gaining knowledge on proper application and what musculoskeletal problems will respond to treatment. More..
Equine extracorporeal shock wave therapy - Extracorporeal shock wave therapy (ESWT) is an accepted form of treatment for chronic cases of proximal suspensory desmitis (PSD). Subjective evaluation of horses shortly after being treated with ESWT has led clinicians to comment on an immediate reduction in lameness. This study aimed to evaluate the analgesic effect of ESWT on 16 horses with PSD or PSD-like pain in a fore- or hindlimb.   More..
​Extracorporeal shock wave therapy: What? Why? Safety? 
Indications for shockwaves in veterinary medicine
Veterinary wound care case study - The following images are of dog bites wounds sustained by a foal approximately one week after birth. She had been in veterinary care, receiving hydrotherapy and daily dressing changes for approximately 13 days prior to Baseline images were taken and the first TRT Multi-wave™ treated applied.  More..
Picture
​Specializing in sales of medical devices using our patented acoustic wave technology to profoundly accelerate healing and recoveries for the human body.
  • 251 Heritage Walk 
    Woodstock, GA 30188​
  • info@trtllc.com​
  • (888) 862-6162

    Please join our quarterly newsletter.

Subscribe to Newsletter
  • About
  • Contact Us
  • FAQ's
  • ​FDA 
  • Investors
  • Customer Portal
  • Meetings
  • Partners
  • Patents
  • Providers

OrthoGold100 is FDA 510K cleared for the activation of connective tissue, treatment of diabetic foot ulcers & registered for pain reduction and improved blood supply.
© Copyright Tissue Regeneration Technologies   |   All Rights Reserved
  • Providers
  • About
    • About Softwave
    • Management
    • Board of Managers
    • Board of Advisors
    • Upcoming Events
  • Research
    • FDA
    • Search
    • SoftWave™ Literature
    • Back, Spine, Nerves
    • Biologic Response
    • Bone Healing
    • Brain, Stroke
    • Cardiology
    • Cancer
    • Cosmetics/Aesthetics
    • Dental
    • Integrative Medicine
    • Modulation of Inflammation
    • Opioid Addiction
    • Organ Regeneration
    • Physics
    • Sports Medicine and Orthopedics >
      • OrthoGold User Guide and Protocols
    • Respiratory/Coronavirus
    • Stem Cells
    • Urology >
      • UroGold IRB User Guide and Protocols
    • Sexual Health
    • Veterinary
    • Wound Care >
      • Wound Care Protocols
    • Research Experts
    • Research Centers
    • Shockwave Summary
  • News
  • Products
    • Cardiology
    • DermaGold100
    • Lithotripsy >
      • Lithotripsy Technical Specifications
      • Lithotripsy F2 Zone Comparison
      • Lithotripsy Imaging
    • Orthopedics >
      • OrthoGold 100™
      • OrthoGold 280™
      • Sport orthopedics and traumatology
    • Urology & Sexual Health
    • Veterinary
    • Wound Care
  • TESTIMONIALS
    • Dr Endorsement Testimonals
    • Cardiology - Stroke
    • Cosmetics
    • Neuropathy
    • Orthopedics
    • Urology & Sexual Health
    • Veterinary
    • Wounds
  • Contact
  • Shop
  • Customer Portal
  • New Page